Related Experiment Video
Updated: Apr 14, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Molecular Insights Into Phytochemicals as Modulators in Oral Squamous Cell Carcinoma
Ali Nakhaei1, Sadaf Afshari2, Pejman Hosseinzadeh2
1Student Research Committee, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
Objective:
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with poor therapeutic outcomes and high recurrence rates. This review aims to summarize the structural, molecular, and analytical mechanisms underlying the anticancer effects of key phytochemicals, including curcumin, resveratrol, and anthocyanins, and other phytochemicals in OSCC.
Methods:
A narrative review was performed based on a structured literature search of PubMed, Scopus, and Web of Science using predefined keywords related to OSCC, phytochemicals, molecular signaling pathways, and analytical characterization. Relevant preclinical and mechanistic studies were critically evaluated.
Results:
Phytochemicals exert anticancer effects in OSCC by modulating major signaling pathways such as PI3K/Akt/mTOR, VEGF, IL-6, Bax/Bcl-2, and MMP2/9, resulting in the regulation of apoptosis, cell proliferation, angiogenesis, and metastasis. Chromatographic and spectroscopic techniques play a pivotal role in the extraction, characterization, quantification, and structural elucidation of phytochemicals, supporting pharmacological standardization. Furthermore, several phytochemicals demonstrate synergistic effects with conventional chemotherapeutic agents and may reduce treatment-associated toxicity.
Conclusion:
This review integrates molecular, structural, and analytical evidence to provide a comparative framework for the role of phytochemicals in OSCC management. Although preclinical data strongly support their therapeutic potential, further analytical refinement and well-designed clinical studies are necessary to translate these findings into effective OSCC treatments.
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

